NASDAQ : TWST
Twist Bioscience Corporation — Financial statements
Healthcare · Diagnostics & Research · United States
Last price 152.78 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 9.58B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Twist Bioscience Corporation (TWST) reported revenue of 431.80M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 431.80M | 376.57M | 312.97M | 245.11M | 203.56M | 132.33M |
| Cost of Revenue | 207.41M | 185.57M | 179.62M | 155.38M | 119.33M | 80.62M |
| Gross Profit | 224.38M | 191.00M | 133.35M | 89.73M | 84.23M | 51.71M |
| Selling, General & Admin | 290.29M | 246.98M | 218.40M | 189.74M | 212.95M | 135.90M |
| Research & Development | 71.86M | 80.28M | 90.85M | 106.89M | 120.31M | 69.07M |
| Operating Expenses | 362.16M | 327.26M | 309.25M | 296.63M | 333.26M | 204.97M |
| Operating Income | -137.77M | -136.26M | -175.90M | -206.90M | -249.02M | -153.26M |
| Interest Expense | -80.00K | -367.00K | ||||
| Interest & Investment Income | 8.02M | 11.36M | 15.34M | 14.37M | 3.06M | 435.00K |
| Other Non Operating Income (Expenses) | 1.11M | -903.00K | -2.68M | -672.00K | -1.09M | |
| EBT Excluding Unusual Items | -128.65M | -125.80M | -163.24M | -193.21M | -247.13M | -153.19M |
| Merger & Restructuring Charges | -9.38M | |||||
| Gain (Loss) on Sale of Assets | 48.85M | 4.61M | ||||
| Asset Writedown | -44.93M | -6.79M | ||||
| Legal Settlements | -7.21M | |||||
| Other Unusual Items | 5.91M | 14.24M | -836.00K | |||
| Pretax Income | -135.85M | -76.95M | -208.17M | -203.47M | -228.27M | -154.03M |
| Income Tax Expense | 864.00K | 719.00K | 560.00K | 1.15M | -10.41M | -1.93M |
| Net Income | -136.72M | -77.67M | -208.73M | -204.62M | -217.86M | -152.10M |
| Net Income to Common | -136.72M | -77.67M | -208.73M | -204.62M | -217.86M | -152.10M |
| Shares Outstanding (Basic) | 61.40M | 59.81M | 58.02M | 56.88M | 53.88M | 48.25M |
| Shares Outstanding (Diluted) | 61.40M | 59.81M | 58.02M | 56.88M | 53.88M | 48.25M |
| EPS (Basic) | -2.23 | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 |
| EPS (Diluted) | -2.23 | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 |
| Free Cash Flow | -93.12M | -75.63M | -69.17M | -170.25M | -226.24M | -139.31M |
| Free Cash Flow Per Share | -1.52 | -1.26 | -1.19 | -2.99 | -4.20 | -2.89 |
| Gross Margin | 51.96% | 50.72% | 42.61% | 36.61% | 41.38% | 39.08% |
| Operating Margin | -31.91% | -36.18% | -56.20% | -84.41% | -122.33% | -115.81% |
| Profit Margin | -31.66% | -20.63% | -66.69% | -83.48% | -107.02% | -114.94% |
| Free Cash Flow Margin | -21.57% | -20.08% | -22.10% | -69.46% | -111.14% | -105.27% |
| EBITDA | -115.28M | -114.31M | -147.07M | -177.59M | -232.51M | -143.51M |
| EBITDA Margin | -26.70% | -30.35% | -46.99% | -72.45% | -114.22% | -108.45% |
| D&A For EBITDA | 22.49M | 21.95M | 28.83M | 29.31M | 16.51M | 9.75M |
| EBIT | -137.77M | -136.26M | -175.90M | -206.90M | -249.02M | -153.26M |
| EBIT Margin | -31.91% | -36.18% | -56.20% | -84.41% | -122.33% | -115.81% |
| Advertising Expenses | 7.00M | 5.20M | 2.90M | 2.40M | 2.50M |
Balance sheet
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 117.44M | 183.05M | 226.32M | 286.47M | 378.69M | 465.83M |
| Short-Term Investments | 49.40M | 49.38M | 50.08M | 49.94M | 126.28M | 12.03M |
| Cash & Short-Term Investments | 166.84M | 232.43M | 276.40M | 336.41M | 504.97M | 477.86M |
| Accounts Receivable | 71.24M | 57.02M | 34.90M | 44.06M | 40.29M | 26.21M |
| Other Receivables | 2.34M | |||||
| Receivables | 71.24M | 57.02M | 34.90M | 44.06M | 40.29M | 28.55M |
| Inventory | 35.16M | 28.31M | 24.08M | 32.06M | 39.31M | 31.80M |
| Prepaid Expenses | 9.96M | 15.20M | 11.40M | 11.72M | 11.91M | 8.28M |
| Total Current Assets | 321.30M | 332.97M | 346.78M | 424.26M | 596.48M | 546.50M |
| Property, Plant & Equipment | 180.62M | 151.66M | 161.35M | 203.36M | 214.39M | 105.70M |
| Long-Term Investments | 68.09M | 54.34M | 1.52M | |||
| Goodwill | 82.19M | 82.19M | 85.81M | 85.81M | 85.81M | 22.43M |
| Other Intangible Assets | 12.73M | 13.43M | 14.48M | 54.48M | 59.74M | 18.26M |
| Other Long-Term Assets | 5.55M | 5.48M | 4.38M | 8.49M | 4.96M | 6.18M |
| Total Assets | 672.44M | 641.86M | 614.32M | 776.40M | 961.38M | 702.10M |
| Accounts Payable | 17.04M | 11.09M | 1.63M | 14.05M | 20.09M | 14.90M |
| Accrued Expenses | 55.33M | 54.34M | 48.75M | 36.57M | 37.19M | 28.76M |
| Current Portion of Long-Term Debt | 1.55M | |||||
| Current Portion of Leases | 8.63M | 13.82M | 14.80M | 14.90M | 13.64M | 8.21M |
| Current Income Taxes Payable | 7.38M | 4.54M | 2.73M | 4.37M | 3.66M | 2.44M |
| Current Unearned Revenue | 6.47M | 6.88M | 2.13M | 3.00M | 3.48M | 1.09M |
| Other Current Liabilities | 25.41M | 722.00K | 961.00K | 430.00K | 12.60M | 6.09M |
| Total Current Liabilities | 120.25M | 91.41M | 71.01M | 73.32M | 90.66M | 63.05M |
| Long-Term Debt | 15.00M | 15.00M | ||||
| Long-Term Leases | 84.96M | 61.75M | 70.22M | 79.17M | 81.27M | 53.16M |
| Other Long-Term Liabilities | 6.48M | 747.00K | 407.00K | 475.00K | 60.00K | 5.07M |
| Total Liabilities | 226.70M | 168.90M | 141.63M | 152.97M | 171.99M | 121.28M |
| Additional Paid-In Capital | 1.88B | 1.79B | 1.72B | 1.66B | 1.62B | 1.19B |
| Retained Earnings | -1.43B | -1.32B | -1.24B | -1.03B | -828.42M | -610.55M |
| Comprehensive Income & Other | -655.00K | -627.00K | -522.00K | -756.00K | -1.84M | 546.00K |
| Total Common Equity | 445.74M | 472.96M | 472.69M | 623.43M | 789.38M | 580.82M |
| Shareholders' Equity | 445.74M | 472.96M | 472.69M | 623.43M | 789.38M | 580.82M |
| Total Liabilities & Equity | 672.44M | 641.86M | 614.32M | 776.40M | 961.38M | 702.10M |
| Total Debt | 108.59M | 90.57M | 85.03M | 94.07M | 94.91M | 62.92M |
| Net Cash (Debt) | 58.25M | 141.86M | 191.37M | 242.34M | 410.06M | 414.94M |
| Net Cash Per Share | 0.95 | 2.37 | 3.30 | 4.26 | 7.61 | 8.60 |
| Filing Date Shares Outstanding | 62.71M | 61.15M | 59.36M | 57.67M | 56.57M | 49.63M |
| Total Common Shares Outstanding | 62.67M | 60.63M | 58.88M | 57.56M | 56.52M | 49.50M |
| Working Capital | 201.04M | 241.56M | 275.77M | 350.93M | 505.82M | 483.44M |
| Book Value Per Share | 7.11 | 7.80 | 8.03 | 10.83 | 13.97 | 11.73 |
| Tangible Book Value | 350.81M | 377.34M | 372.40M | 483.14M | 643.84M | 540.12M |
| Tangible Book Value Per Share | 5.60 | 6.22 | 6.33 | 8.39 | 11.39 | 10.91 |
| Machinery | 121.07M | 107.88M | 105.93M | 111.18M | 67.43M | 53.61M |
| Construction In Progress | 19.55M | 20.12M | 4.69M | 8.53M | 87.72M | 16.97M |
| Leasehold Improvements | 68.54M | 58.28M | 57.45M | 57.27M | 14.37M | 5.07M |
Cash flow statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -136.72M | -77.67M | -208.73M | -204.62M | -217.86M | -152.10M |
| Depreciation & Amortization | 22.49M | 21.95M | 28.83M | 29.31M | 16.51M | 9.75M |
| Other Amortization | 2.90M | 2.90M | 2.60M | |||
| Loss (Gain) From Sale of Assets | -48.85M | -4.61M | ||||
| Asset Writedown & Restructuring Costs | 44.93M | 6.79M | ||||
| Stock-Based Compensation | 66.47M | 64.46M | 50.92M | 30.28M | 79.66M | 37.00M |
| Other Operating Activities | -453.00K | 2.18M | 1.93M | -3.22M | 7.26M | 2.49M |
| Change in Accounts Receivable | -15.71M | -22.38M | 8.44M | -4.32M | -9.62M | -2.20M |
| Change in Inventory | -9.22M | -4.23M | 7.99M | 7.24M | -7.54M | -19.49M |
| Change in Accounts Payable | 4.30M | 9.33M | -11.80M | -2.51M | 7.38M | 8.54M |
| Change in Other Net Operating Assets | 12.87M | 4.67M | 10.79M | -1.42M | 4.42M | 3.77M |
| Operating Cash Flow | -53.07M | -47.63M | -64.09M | -142.47M | -124.39M | -112.24M |
| Capital Expenditures | -40.05M | -28.00M | -5.08M | -27.78M | -101.86M | -27.06M |
| Cash Acquisitions | -8.16M | -483.00K | ||||
| Divestitures | 2.50M | -5.75M | ||||
| Investment in Securities | -89.00K | 742.00K | 2.00M | 78.39M | -117.16M | 183.70M |
| Investing Cash Flow | -45.24M | -24.76M | -3.07M | 50.61M | -232.93M | 156.16M |
| Long-Term Debt Repaid | -1.56M | -3.33M | ||||
| Net Debt Issued (Repaid) | -1.56M | -3.33M | ||||
| Issuance of Common Stock | 13.81M | 13.56M | 10.87M | 5.32M | 279.85M | 343.36M |
| Repurchase of Common Stock | -18.00K | -16.00K | -3.98M | -4.41M | -7.75M | -10.85M |
| Other Financing Activities | 15.00M | |||||
| Financing Cash Flow | 13.80M | 28.54M | 6.89M | 911.00K | 270.53M | 329.18M |
| Foreign Exchange Rate Adjustments | 176.00K | 143.00K | 126.00K | -27.00K | -319.00K | 20.00K |
| Net Cash Flow | -84.34M | -43.71M | -60.15M | -90.98M | -87.10M | 373.11M |
| Free Cash Flow | -93.12M | -75.63M | -69.17M | -170.25M | -226.24M | -139.31M |
| Free Cash Flow Margin | -21.57% | -20.08% | -22.10% | -69.46% | -111.14% | -105.27% |
| Free Cash Flow Per Share | -1.52 | -1.26 | -1.19 | -2.99 | -4.20 | -2.89 |
| Levered Free Cash Flow | -64.82M | -32.63M | -17.42M | -112.43M | -160.52M | -73.09M |
| Unlevered Free Cash Flow | -64.82M | -32.63M | -17.42M | -112.43M | -160.47M | -72.86M |
| Cash Interest Paid | 9.00K | 167.00K | ||||
| Cash Income Tax Paid | 1.19M | 683.00K | 344.00K | 420.00K | 246.00K | 101.00K |
| Change in Working Capital | -7.76M | -12.61M | 15.41M | -1.01M | -5.36M | -9.38M |
Ratios
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 9.47B | 1.70B | 2.65B | 1.16B | 1.99B | 5.27B |
| Enterprise Value | 9.41B | 1.54B | 2.44B | 898.73M | 1.54B | 4.82B |
| Last Close Price | 152.78 | 28.14 | 45.18 | 20.26 | 35.24 | 106.97 |
| PS Ratio | 22.19 | 4.51 | 8.46 | 4.74 | 9.76 | 39.84 |
| PB Ratio | 21.48 | 3.59 | 5.60 | 1.86 | 2.52 | 9.08 |
| P/TBV Ratio | 27.31 | 4.50 | 7.11 | 2.41 | 3.08 | 9.76 |
| EV/Sales Ratio | 22.05 | 4.09 | 7.81 | 3.67 | 7.55 | 36.40 |
| Debt / Equity Ratio | 0.24 | 0.19 | 0.18 | 0.15 | 0.12 | 0.11 |
| Net Debt / Equity Ratio | -0.13 | -0.30 | -0.41 | -0.39 | -0.52 | -0.71 |
| Net Debt / EBITDA Ratio | 0.51 | 1.24 | 1.30 | 1.36 | 1.76 | 2.89 |
| Net Debt / FCF Ratio | 0.63 | 1.88 | 2.77 | 1.42 | 1.81 | 2.98 |
| Asset Turnover | 0.66 | 0.60 | 0.45 | 0.28 | 0.24 | 0.24 |
| Inventory Turnover | 6.79 | 7.08 | 6.40 | 4.35 | 3.36 | 3.66 |
| Quick Ratio | 1.98 | 3.17 | 4.38 | 5.19 | 6.01 | 8.03 |
| Current Ratio | 2.67 | 3.64 | 4.88 | 5.79 | 6.58 | 8.67 |
| Return on Equity (ROE) | -29.59% | -16.43% | -38.08% | -28.97% | -31.80% | -33.17% |
| Return on Assets (ROA) | -13.09% | -13.56% | -15.81% | -14.88% | -18.71% | -17.40% |
| Return on Capital Employed (ROCE) | -25.00% | -24.80% | -32.40% | -29.40% | -28.60% | -24.00% |
| Earnings Yield | -1.48% | -4.57% | -7.89% | -17.60% | -10.97% | -2.89% |
| FCF Yield | -0.97% | -4.45% | -2.61% | -14.64% | -11.39% | -2.64% |
| Buyback Yield / Dilution | -3.44% | -3.09% | -1.99% | -5.57% | -11.68% | -23.12% |